Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-11

Clinical Trial Update: Could Dietary Algae Affect Immunity and Viral Counts in People With HIV? [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial assessing whether dietary algae can influence immunity and viral counts in people with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of South Carolina | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED